Finance

Lists
AUROPHARMA:NSE
Aurobindo Pharma Ltd
၁,၆၆၆.၉၀ ₹
-၀.၆၆%
(-၁၁.၀၀) 1D
အောက် ၁၆, GMT+၅:၃၀ ၁၅:၃၀:၀၀  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for AUROPHARMA...
Open
၁,၆၇၇.၉၀ ₹
High
၁,၆၈၁.၇၀ ₹
Low
၁,၆၅၅.၀၀ ₹
Mkt. cap
ဋေ ၉.၅၉ သ
Avg. vol.
၇.၇၉ သိန်း
Volume
၇.၉၇ သိန်း
P/E ratio
၂၆.၀၄
52-wk high
၁,၇၄၀.၀၀ ₹
52-wk low
၁,၀၈၀.၁၀ ₹
EPS
၆၄.၀၀ ₹
Shares outstanding
၅၈.၅၉ ကုဋေ
No. of employees
၃ သောင်း
Open
၁,၆၇၇.၉၀ ₹
High
၁,၆၈၁.၇၀ ₹
Low
၁,၆၅၅.၀၀ ₹
Mkt. cap
ဋေ ၉.၅၉ သ
Avg. vol.
၇.၇၉ သိန်း
Volume
၇.၉၇ သိန်း
P/E ratio
၂၆.၀၄
52-wk high
၁,၇၄၀.၀၀ ₹
52-wk low
၁,၀၈၀.၁၀ ₹
EPS
၆၄.၀၀ ₹
Shares outstanding
၅၈.၅၉ ကုဋေ
No. of employees
၃ သောင်း
News stories
From web sources and news partners
GlobeNewswire
GlobeNewswire
·
ပြီးခဲ့သည့် ၁ နာရီ
OpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksight
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၄ မိနစ်
Top Growth Stocks With Insider Buying For October 2026
www.marketscreener.com
www.marketscreener.com
·
ပြီးခဲ့သည့် ၂၀ မိနစ်
Inter & Co, Inc.(NasdaqGS: INTR) added to S&P Global BMI Index
Bloomberg.com
Bloomberg.com
·
ပြီးခဲ့သည့် ၂ နာရီ
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Profile
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company based in HITEC City, Hyderabad, with U.S. headquarters in East Windsor, Mercer County, New Jersey. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include Pfizer and AstraZeneca. Wikipedia
About Aurobindo Pharma Ltd
CEO-
Employees၂.၉၂ သောင်း
Founded၁၉၈၆
HeadquartersHyderabad, အန်ဒရာပရာဒစ် ပြည်နယ်, အိန္ဒိယ
Sector-
Last report
၂၀၂၆ ဩ ၆
Fiscal period
Q1 2027
၁၇.၄၆ ₹ / ၁၇.၂၆ ₹
+၁.၁၇%beat
Revenue / Est. (INR)
ဋေ ၉.၁၅ ထ / ဋေ ၉.၀၀ ထ
+၁.၆၉%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
ဋေ ၈.၂၉ ထ
ဋေ ၈.၆၅ ထ
ဋေ ၈.၈၅ ထ
ဋေ ၉.၁၅ ထ
Cost of goods sold
ဋေ ၃.၃၄ ထ
ဋေ ၃.၄၈ ထ
ဋေ ၃.၉၃ ထ
ဋေ ၃.၆၃ ထ
Cost of revenue
ဋေ ၃.၃၄ ထ
ဋေ ၃.၄၈ ထ
ဋေ ၃.၉၃ ထ
ဋေ ၃.၆၃ ထ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
ဋေ ၁.၂၈ ထ
ဋေ ၁.၃၁ ထ
ဋေ ၁.၄၃ ထ
ဋေ ၁.၄၈ ထ
Operating expense
ဋေ ၃.၇၀ ထ
ဋေ ၃.၈၆ ထ
ဋေ ၃.၅၃ ထ
ဋေ ၄.၁၃ ထ
Total operating expenses
ဋေ ၇.၀၄ ထ
ဋေ ၇.၃၄ ထ
ဋေ ၇.၄၆ ထ
ဋေ ၇.၇၆ ထ
Operating income
ဋေ ၁.၂၅ ထ
ဋေ ၁.၃၁ ထ
ဋေ ၁.၄၀ ထ
ဋေ ၁.၃၉ ထ
Other non operating income
၁၁၅.၆၁ ဋေ
၁၅၄.၁၄ ဋေ
-၂၅၁.၄၃ ဋေ
၂၁၁.၆၁ ဋေ
EBT including unusual items
ဋေ ၁.၂၈ ထ
ဋေ ၁.၃၄ ထ
ဋေ ၁.၂၉ ထ
ဋေ ၁.၅၂ ထ
EBT excluding unusual items
ဋေ ၁.၂၈ ထ
ဋေ ၁.၄၀ ထ
ဋေ ၁.၃၆ ထ
ဋေ ၁.၅၆ ထ
Income tax expense
၄၂၇.၇၉ ဋေ
၄၂၈.၇၂ ဋေ
၃၆၉.၇၇ ဋေ
၄၈၃.၀၆ ဋေ
Effective tax rate
၃၃.၅၃%
၃၂.၀၃%
၂၈.၆၅%
၃၁.၈၈%
Other operating expenses
ဋေ ၁.၉၉ ထ
ဋေ ၂.၀၈ ထ
ဋေ ၁.၆၄ ထ
ဋေ ၂.၁၆ ထ
Net income
၈၄၈.၄၅ ဋေ
၉၁၀.၂၉ ဋေ
၉၂၁.၂၆ ဋေ
ဋေ ၁.၀၃ ထ
Net profit margin
၁၀.၂၄%
၁၀.၅၃%
၁၀.၄၁%
၁၁.၂၈%
Earnings per share
၁၄.၆၁
၁၆.၄၃
၁၅.၈၆
၁၇.၄၆
Interest and investment income
-
-
၃၃၁.၃၅ ဋေ
-
Interest expense
-၉၅.၂၄ ကုဋေ
-၉၂.၇၇ ကုဋေ
-၆၆.၅၅ ကုဋေ
-၁၀၁.၆၆ ဋေ
Net interest expenses
-၉၅.၂၄ ကုဋေ
-၉၂.၇၇ ကုဋေ
၂၆၄.၈၀ ဋေ
-၁၀၁.၆၆ ဋေ
Depreciation and amortization charges
၄၂၉.၁၉ ဋေ
၄၆၄.၇၃ ဋေ
၄၆၁.၀၃ ဋေ
၄၈၆.၈၂ ဋေ
EBITDA
ဋေ ၁.၆၇ ထ
ဋေ ၁.၆၇ ထ
ဋေ ၁.၈၀ ထ
ဋေ ၁.၈၀ ထ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google အက်ပ်များ